[HTML][HTML] The biology of TREM receptors

M Colonna - Nature Reviews Immunology, 2023 - nature.com
Triggering receptors expressed on myeloid cells (TREMs) encompass a family of cell-
surface receptors chiefly expressed by granulocytes, monocytes and tissue macrophages …

[HTML][HTML] APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer's disease pathology and brain diseases

R Fernández-Calle, SC Konings… - Molecular …, 2022 - Springer
ApoE is the major lipid and cholesterol carrier in the CNS. There are three major human
polymorphisms, apoE2, apoE3, and apoE4, and the genetic expression of APOE4 is one of …

Challenges and hopes for Alzheimer's disease

SA Tatulian - Drug discovery today, 2022 - Elsevier
Recent drug development efforts targeting Alzheimer's disease (AD) have failed to produce
effective disease-modifying agents for many reasons, including the substantial …

[HTML][HTML] Astrocyte-neuron metabolic cooperation shapes brain activity

G Bonvento, JP Bolaños - Cell metabolism, 2021 - cell.com
The brain has almost no energy reserve, but its activity coordinates organismal function, a
burden that requires precise coupling between neurotransmission and energy metabolism …

Microglia in Alzheimer's disease at single-cell level. Are there common patterns in humans and mice?

Y Chen, M Colonna - Journal of Experimental Medicine, 2021 - rupress.org
Alzheimer's disease (AD) is characterized by extracellular aggregates of amyloid β peptides,
intraneuronal tau aggregates, and neuronal death. This pathology triggers activation of …

[HTML][HTML] White matter aging drives microglial diversity

S Safaiyan, S Besson-Girard, T Kaya… - Neuron, 2021 - cell.com
Aging results in gray and white matter degeneration, but the specific microglial responses
are unknown. Using single-cell RNA sequencing from white and gray matter separately, we …

[HTML][HTML] Cholesterol and Alzheimer's disease; from risk genes to pathological effects

FM Feringa, R Van der Kant - Frontiers in Aging Neuroscience, 2021 - frontiersin.org
While the central nervous system compromises 2% of our body weight, it harbors up to 25%
of the body's cholesterol. Cholesterol levels in the brain are tightly regulated for …

[HTML][HTML] APOE mediated neuroinflammation and neurodegeneration in Alzheimer's disease

S Parhizkar, DM Holtzman - Seminars in immunology, 2022 - Elsevier
Neuroinflammation is a central mechanism involved in neurodegeneration as observed in
Alzheimer's disease (AD), the most prevalent form of neurodegenerative disease …

[HTML][HTML] Cholesterol metabolism in aging and age-related disorders

G Saher - Annual Review of Neuroscience, 2023 - annualreviews.org
All mammalian cell membranes contain cholesterol to maintain membrane integrity. The
transport of this hydrophobic lipid is mediated by lipoproteins. Cholesterol is especially …

[HTML][HTML] The COVID-19 pandemic and Alzheimer's disease: mutual risks and mechanisms

F Chen, Y Chen, Y Wang, Q Ke, L Cui - Translational neurodegeneration, 2022 - Springer
Abstract Coronavirus disease 2019 (COVID-19), which is caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is a life-threatening disease, especially …